Panacea Biotec Limited Share Price and Company Fundamentals
Last traded: Last Thursday at 9:59 AM
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. The company operates through Vaccines and Pharmaceutical Formulations & Nutrition segments. Its product portfolio includes prescription products in various therapeutic areas, such as diabetes, gastro-intestinal care, nephrology, oncology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, and Mpox, etc. The company also offers health supplement products; and nutrition products under the ChilRun full, ChilRun 7+, and ChillRun No Sucrose brands. In addition, it engages in the real estate business. It exports its products to approximately 50 countries. It has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Key Metrics
PE ratio
-
PB ratio
2.79
Dividend yield
-
Beta
0.26
Market cap
₹21.96B
Enterprise value
₹21.16B
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Full time employees | 2102 |
| Website | https://www.panaceabiotec.com |
| Mailing address | B-1 Extn./A-27 Mohan Co-operative Industrial Estate Mathura Road New Delhi 110044 India |
| Phone / Fax | 91 11 4167 9000 / 91 11 4167 9070 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Panacea Biotec Limited paid ₹- dividend and the ex-dividend date was 19 Sep 2011.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PANACEABIO dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Oct 2026, following are the company executives and directors listed on Panacea Biotec Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Rajesh Jain Ph.D. | Chairman of the Board & MD | 61 | |
| Mr. Sandeep Jain | Joint MD & Executive Director | 59 | |
| Mr. Vinod Goel | Group CFO and Head of Legal & Corporate Governance | 60 | |
| Dr. Khalid Ali Syed | Chief Scientific Officer | 50 | |
| Mr. Ankit Jain | GM of Legal, Company Secretary & Compliance Officer | 37 | |
| Mr. Gurinder Pal Singh | Senior Vice President of Sales | 58 | |
| Dr. Sanjay Trehan | Director Technical & Compliances and Whole -Time Director | 66 | |
| Mr. Ankesh Jain | Whole-Time Director | 37 | |
| Mr. Harshet Jain | Whole - Time Director | 33 | |
| Dr. Naveen Kumar Jain | Senior Vice President of New Product Initiatives & Project Management | 53 |
Profitability and management effectiveness
Profit margin
-1.06%
Operating margin
-1.12%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Panacea Biotec Limited is 21.96B and its enterprise value is 21.16B. The enterprise value to revenue ratio of PANACEABIO is 3.15. The enterprise value to EBITDA ratio of PANACEABIO is 731.97.
The PANACEABIO's stocks Beta value is 0.26 making it 74% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Panacea Biotec Limited (NSE:PANACEABIO) Frequently Asked Questions
1. What is Panacea Biotec Limited's Stock Symbol?
Panacea Biotec Limited trades on NSE under the ticker symbol "PANACEABIO".
2. What is Panacea Biotec Limited's stock price today?
One share of PANACEABIO stock can currently be purchased for approximately ₹358.5.
3. How can I contact Panacea Biotec Limited?
Panacea Biotec Limited's mailing address is B-1 Extn./A-27 Mohan Co-operative Industrial Estate Mathura Road New Delhi 110044 India. The company can be reached via phone at 91 11 4167 9000.
4. What is Panacea Biotec Limited's official website?
The official website of Panacea Biotec Limited is https://www.panaceabiotec.com.